369 related articles for article (PubMed ID: 16290173)
1. Does the cell wall of bacteria remain a viable source of targets for novel antibiotics?
Silver LL
Biochem Pharmacol; 2006 Mar; 71(7):996-1005. PubMed ID: 16290173
[TBL] [Abstract][Full Text] [Related]
2. Peptide inhibitors of MurD and MurE, essential enzymes of bacterial cell wall biosynthesis.
Bratkovic T; Lunder M; Urleb U; Strukelj B
J Basic Microbiol; 2008 Jun; 48(3):202-6. PubMed ID: 18506905
[TBL] [Abstract][Full Text] [Related]
3. Viable screening targets related to the bacterial cell wall.
Silver LL
Ann N Y Acad Sci; 2013 Jan; 1277():29-53. PubMed ID: 23278681
[TBL] [Abstract][Full Text] [Related]
4. Targeting the forgotten transglycosylases.
Halliday J; McKeveney D; Muldoon C; Rajaratnam P; Meutermans W
Biochem Pharmacol; 2006 Mar; 71(7):957-67. PubMed ID: 16298347
[TBL] [Abstract][Full Text] [Related]
5. Exploiting current understanding of antibiotic action for discovery of new drugs.
Chopra I; Hesse L; O'Neill AJ
Symp Ser Soc Appl Microbiol; 2002; (31):4S-15S. PubMed ID: 12481824
[TBL] [Abstract][Full Text] [Related]
6. Action of clofoctol on bacterial cell wall synthesis.
Yablonsky F; Simonnet G
J Pharmacol; 1982; 13(4):515-24. PubMed ID: 7154664
[TBL] [Abstract][Full Text] [Related]
7. The discovery of cell wall active antibacterial antibiotics.
Gadebusch HH; Stapley EO; Zimmerman SB
Crit Rev Biotechnol; 1992; 12(3):225-43. PubMed ID: 1633621
[No Abstract] [Full Text] [Related]
8. Future chemotherapy, with emphasis on bacterial murein.
Koch AL
FEMS Immunol Med Microbiol; 2006 Mar; 46(2):158-65. PubMed ID: 16487296
[No Abstract] [Full Text] [Related]
9. Emerging bacterial enzyme targets.
Su Z; Honek JF
Curr Opin Investig Drugs; 2007 Feb; 8(2):140-9. PubMed ID: 17328230
[TBL] [Abstract][Full Text] [Related]
10. Lighting up the nascent cell wall.
van der Donk WA
ACS Chem Biol; 2006 Aug; 1(7):425-8. PubMed ID: 17168519
[TBL] [Abstract][Full Text] [Related]
11. [Kinds of antimicrobial agents and their mode of actions].
Yokota T
Nihon Rinsho; 1997 May; 55(5):1155-60. PubMed ID: 9155168
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of N-acylhydrazones as inhibitors of MurC and MurD ligases.
Sink R; Kovac A; Tomasić T; Rupnik V; Boniface A; Bostock J; Chopra I; Blanot D; Masic LP; Gobec S; Zega A
ChemMedChem; 2008 Sep; 3(9):1362-70. PubMed ID: 18651694
[TBL] [Abstract][Full Text] [Related]
13. An oldie but a goodie - cell wall biosynthesis as antibiotic target pathway.
Schneider T; Sahl HG
Int J Med Microbiol; 2010 Feb; 300(2-3):161-9. PubMed ID: 20005776
[TBL] [Abstract][Full Text] [Related]
14. A multivalent approach to drug discovery for novel antibiotics.
Long DD; Aggen JB; Christensen BG; Judice JK; Hegde SS; Kaniga K; Krause KM; Linsell MS; Moran EJ; Pace JL
J Antibiot (Tokyo); 2008 Oct; 61(10):595-602. PubMed ID: 19168973
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel disaccharide antibacterial agents using a combinatorial library approach.
Sofia MJ; Allanson N; Hatzenbuhler NT; Jain R; Kakarla R; Kogan N; Liang R; Liu D; Silva DJ; Wang H; Gange D; Anderson J; Chen A; Chi F; Dulina R; Huang B; Kamau M; Wang C; Baizman E; Branstrom A; Bristol N; Goldman R; Han K; Longley C; Axelrod HR
J Med Chem; 1999 Aug; 42(17):3193-8. PubMed ID: 10464005
[No Abstract] [Full Text] [Related]
16. Resistance mapping and mode of action of a novel class of antibacterial anthranilic acids: evidence for disruption of cell wall biosynthesis.
Mott JE; Shaw BA; Smith JF; Bonin PD; Romero DL; Marotti KR; Miller AA
J Antimicrob Chemother; 2008 Oct; 62(4):720-9. PubMed ID: 18567575
[TBL] [Abstract][Full Text] [Related]
17. Peptidoglycan biosynthesis machinery: a rich source of drug targets.
Gautam A; Vyas R; Tewari R
Crit Rev Biotechnol; 2011 Dec; 31(4):295-336. PubMed ID: 21091161
[TBL] [Abstract][Full Text] [Related]
18. [Advances in the research of inhibitors of enzymes of bacterial peptidoglycan biosynthesis].
Liu F; Meng HY; Sun ZY; Li DY; Jin YY; Yang ZY; Wu SJ; Chen J
Yao Xue Xue Bao; 2017 Mar; 52(3):362-70. PubMed ID: 29979555
[TBL] [Abstract][Full Text] [Related]
19. Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships.
Charifson PS; Grillot AL; Grossman TH; Parsons JD; Badia M; Bellon S; Deininger DD; Drumm JE; Gross CH; LeTiran A; Liao Y; Mani N; Nicolau DP; Perola E; Ronkin S; Shannon D; Swenson LL; Tang Q; Tessier PR; Tian SK; Trudeau M; Wang T; Wei Y; Zhang H; Stamos D
J Med Chem; 2008 Sep; 51(17):5243-63. PubMed ID: 18690678
[TBL] [Abstract][Full Text] [Related]
20. Dihydrofolate reductase inhibitors as antibacterial agents.
Hawser S; Lociuro S; Islam K
Biochem Pharmacol; 2006 Mar; 71(7):941-8. PubMed ID: 16359642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
